Ticker: RXRX

Company: RECURSION PHARMACEUTICALS, INC.

Person: Blake Borgeson, director

Transaction date: Jan. 6, 2026

Reporting date: Jan. 8, 2026

Average share price: 4.36

Sold 220000.0 shares for 959200.0